Somatic Cell Nuclear Transfer Reprogramming: Mechanisms and Applications

Shogo Matoba; Yi Zhang

doi:10.1016/j.stem.2018.06.018

Somatic Cell Nuclear Transfer Reprogramming: Mechanisms and Applications

Cell Stem Cell. 2018 Oct 4;23(4):471-485. doi: 10.1016/j.stem.2018.06.018. Epub 2018 Jul 19.

Authors

Shogo Matoba¹, Yi Zhang²

Affiliations

¹ RIKEN Bioresource Research Center, Tsukuba, Ibaraki 305-0074, Japan; Cooperative Division of Veterinary Sciences, Tokyo University of Agriculture and Technology, Fuchu, Tokyo 183-8509, Japan. Electronic address: shogo.matoba@riken.jp.
² Howard Hughes Medical Institute; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Boston, MA 02115, USA. Electronic address: yzhang@genetics.med.harvard.edu.

Abstract

Successful cloning of monkeys, the first non-human primate species, by somatic cell nuclear transfer (SCNT) attracted worldwide attention earlier this year. Remarkably, it has taken more than 20 years since the cloning of Dolly the sheep in 1997 to achieve this feat. This success was largely due to recent understanding of epigenetic barriers that impede SCNT-mediated reprogramming and the establishment of key methods to overcome these barriers, which also allowed efficient derivation of human pluripotent stem cells for cell therapy. Here, we summarize recent advances in SCNT technology and its potential applications for both reproductive and therapeutic cloning.

Keywords: epigenetic reprogramming; human disease model generation; iPSC; reproductive cloning; somatic cell nuclear transfer; therapeutic cloning.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Cellular Reprogramming*
Humans
Mesenchymal Stem Cell Transplantation
Nuclear Transfer Techniques*
Pluripotent Stem Cells

Abstract

Publication types

MeSH terms

Grants and funding